A core outcome set for efficacy of acute treatment of hereditary angioedema
|
591. |
Petersen, R. S., Fijen, L. M., Apfelbacher, C., Magerl, M., Weller, K., Aberer, W., Adatia, A., Audhya, P., Bara, N. A., Betschel, S., Boccon-Gibod, I., Bouillet, L., Brodszki, N., Busse, P. J., Buttgereit, T., Bygum, A., Cancian, M., Craig, T., Csuka, D., Farkas, H., Fomina, D., Gil-Serrano, J., Gompels, M., Fogelbach, G. G., Guilarte, M., Hide, M., Kiani-Alikhan, S., Kinaciyan, T., Lenten, A., Lleonart, R., Longhurst, H., Lumry, W. R., Malbran, A., Malinauskiene, L., Matta Campos, J. J., Mendivil, J., Nieto-Martinez, S. A., Peter, J. G., Porebski, G., Reshef, A., Riedl, M., Valerieva, A., Waserman, S., Maurer, M., and Cohn, D. M.+: A core outcome set for efficacy of acute treatment of hereditary angioedema. J. Allergy Clin. Immunol. Pract. 2024: 12; 1614-1621. IF: 6.60 |
o.591
A core outcome set for efficacy of acute treatment of hereditary angioedema Read More »